TNF and Alzheimer disease: Neuroinflammatory, a crucial response for the development of AD (Morales et al., 2014), was shown to be inhibited by NMN treatment in AD-Tg mice (Yao et al., 2017), including decrease in IL-6, IL-1β, and TNFα.